Facetten
Zugriff
Einrichtung
Medientyp
- Text 16
Karte
Erscheinungsjahr
Autor/in
- Benner, Axel
- Chang-Claude, Jenny 5
- Bertsch, Uta 3
- Hoffmeister, Michael 3
- Jansen, Lina 3
- alle zeigen
Sprache
16 Einträge gefunden
-
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
- Salwender, Hans
- Elmaagacli, Ahmet
- Merz, Maximilian
- Miah, Kaya
- Benner, Axel
- Haenel, Mathias
- Jehn, Christian
-
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
- Klein, Eva-Maria
- Tichy, Diana
- Salwender, Hans J
- Mai, Elias K
- Duerig, Jan
- Weisel, Katja C
- Benner, Axel
-
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
2019 - Forschungsinformationssystem des UKE - frei zugänglich -
Pre- to postdiagnosis leisure-time physical activity and prognosis in postmenopausal breast cancer survivors
- Jung, Audrey Y
- Behrens, Sabine
- Schmidt, Martina
- Thoene, Kathrin
- Obi, Nadia
- Hüsing, Anika
- Benner, Axel
-
-
-
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer
- Maierthaler, Melanie
- Benner, Axel
- Hoffmeister, Michael
- Surowy, Harald
- Jansen, Lina
- Knebel, Phillip
- Chang-Claude, Jenny
-
-
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy
- Hütter-Krönke, Marie-Luise
- Benner, Axel
- Döhner, Konstanze
- Krauter, Jürgen
- Weber, Daniela
- Moessner, Margit
- Köhne, Claus-Henning
-
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study
- Schlenk, Richard F
- Lübbert, Michael
- Benner, Axel
- Lamparter, Alexander
- Krauter, Jürgen
- Herr, Wolfgang
- Martin, Hans
-
-
-
-
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
- Remke, Marc
- Hielscher, Thomas
- Korshunov, Andrey
- Northcott, Paul A
- Bender, Sebastian
- Kool, Marcel
- Westermann, Frank
-
-